Drug Trial Radar · NCT04908683
A Study of an Adenovirus Serotype 26 Pre-fusion Conformation-stabilized F Protein (Ad26. RSV. preF) Based Respiratory Syncytial Virus (RSV) Vaccine in the Prevention of Lower Respiratory Tract Disease in Adults Aged 60 Years and Older
Last checked: Nov 19, 2026Latest source record: Nov 13, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
25,236
Actual
Start
Jul 21, 2021
Primary completion
Jul 21, 2023
Study completion Jul 21, 2023
Sponsor
- Lead sponsor
- Janssen Vaccines & Prevention B.V.Johnson & Johnson (Janssen) (JNJ)
- Sponsor type
- Industry
- First posted
- Jun 1, 2021
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Prevention
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 60 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The study will enroll up to 27,200 participants in order to demonstrate the efficacy of the active Ad26.RSV.preF-based study vaccine in the prevention of Reverse Transcription Polymerase Chain Reaction (RT-PCR) confirmed Respiratory Syncytial Virus (RSV)-mediated Lower Respiratory Tract Disease (LRTD) when compared to placebo in adults aged 60 years and above.
Conditions
- Respiratory Syncytial Viruses
- Lower Respiratory Tract Disease
Interventions
Adenovirus serotype 26 (Ad26)-based respiratory syncytial virus (RSV). preFBiological
Participants will receive a single IM injection of an RSV vaccine.
PlaceboBiological
Participants will receive a single IM injection of matching placebo.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Participants With First Occurrence of Reverse Transcriptase Polymerase Chain Reaction (RT-PCR)-Confirmed Respiratory Syncytial Virus (RSV) Mediated Lower Respiratory Tract Disease (LRTD)Time frame: From Baseline (Day 1) up to 12 months
Locations
272 sites in 14 countries. Site status is shown where the registry gives one.
Central Research Associates, Inc.
Birmingham, Alabama
Synexus Clinical Research US Inc
Birmingham, Alabama
Achieve Clinical Research, LLC
Birmingham, Alabama
Optimal Research
Huntsville, Alabama
Coastal Clinical Research, Inc
Mobile, Alabama
Synexus Clinical Research US Inc
Chandler, Arizona
Hope Research Institute
Peoria, Arizona
Central Phoenix Medical Clinic
Phoenix, Arizona
Medpharmics, LLC
Phoenix, Arizona
Clinical Research Consortium Arizona
Tempe, Arizona
Synexus Clinical Research US Inc
Tucson, Arizona
Baptist Health Center For Clinical Research
Little Rock, Arkansas
Rancho Paseo Medical Group
Banning, California
Hope clinical Research LLC
Canoga Park, California
Synexus Clinical Research US Inc
Cerritos, California
eStudySite
Chula Vista, California
Velocity Clinical Research, San Diego
La Mesa, California
Paradigm Clinical Research Centers, Inc.
Redding, California
Optimal Research
San Diego, California
Encompass Clinical Research
Spring Valley, California
Synexus Clinical Research US Inc
Vista, California
Synexus Clinical Research US Inc
Aurora, Colorado
Tekton Research Inc.
Fort Collins, Colorado
Tekton Research Inc.
Longmont, Colorado
Paradigm Clinical Research Centers, Inc.
Wheat Ridge, Colorado
JEM Research LLC
Atlantis, Florida
Clinical Research of South Florida, an AMR Company
Coral Gables, Florida
Prestige Clinical Research Center, Inc.
Coral Gables, Florida
Avail Clinical Research, LLC
DeLand, Florida
Velocity Clinical Research, Inc.
Edgewater, Florida
AMR Fort Myers Clinical Physiology Associates, an AMR company
Fort Myers, Florida
Velocity Clinical Research, Hallandale Beach
Hallandale, Florida
Westside Center for Clinical Research
Jacksonville, Florida
Jacksonville Center For Clinical Research
Jacksonville, Florida
Altus Research, Inc
Lake Worth, Florida
Accel Research Sites
Lakeland, Florida
Compass Research LLC
Leesburg, Florida
Optimal Research
Melbourne, Florida
Suncoast Research Group
Miami, Florida
New Horizon Research Center
Miami, Florida
Showing 40 of 272 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.